The Swedish healthcare firm, which owns medical device company Maquet, posted profits of roughly $95.6 million, or 40¢ per share, on sales of $1.74 billion for the 6 months ended June 30.
Getinge (PINK:GETI B) subsidiary Maquet Cardiovascular racked up a win for another of its devices designed to close artery incisions for catheters after the FDA cleared its Air-Band radial compression device for the U.S. market.
The device is designed to help seal the radial artery after a catheterization procedure, in which the catheter is threaded into the heart via a radial artery incision in the wrist.
Maquet Cardiovascular landed FDA 510(k) clearance and CE Mark approval in the European Union for a new version of its intra-aortic balloon catheters, the Sensation Plus 7.5Fr 40cc.
The larger-volume fiber optic IAB catheter, designed for smaller patients between 5’0" and 5’4", will be on the market in the U.S. and E.U. in October, according to a press release.
Physicians and medical boards may have to reconsider decades of cardiogenic shock treatment after the highly anticipated IABP-Shock study found no significant benefit in using intra-aortic balloon pump therapy in heart attack patients.
Novation said members of VHA Inc., UHC and Provista LLC can nab discounts of up to 71% on capital equipment fromJuly through September.
The group purchasing organization said the discounts include medical devices ranging from centrifuges and patient beds to CT scanners and nuclear medicine equipment.